As reported here early earlier, Guidant has a problem with some of its defibrillators and has know about it for over three years. Now, it appears that it disclosed at least a part of what it knew to the FDA in February but the FDA did not act until June.
The New York Times just got the report under a FOIA request – a request orginally rejected by the FDA.
Read more here. For my other posts on this subject click here and here.